Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution-Reference-Cited by-同舟云学术

Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution

Published:2015-10-02 Issue:12 Volume:58 Page:694-698
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Tzadok Roie¹,Shapira Michael Y.²,Moses Allon E.¹,Or Reuven²,Block Colin¹,Strahilevitz Jacob¹

Affiliation:

1. Department of Clinical Microbiology and Infectious Diseases; Hadassah-Hebrew University Medical Center; Jerusalem Israel

2. Department of Bone Marrow Transplantation & Cancer Immunotherapy; Hadassah-Hebrew University Medical Center; Jerusalem Israel

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Reference26 articles.

1. New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients;Zuccotti;Expert Opin Pharmacother,2005

2. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients;Barnes;Br J Haematol,2007

3. Combination antifungal therapy for invasive aspergillosis: a randomized trial;Marr;Ann Intern Med,2015

4. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis;Robenshtok;J Clin Oncol,2007

5. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients;Marr;Clin Infect Dis,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of endogenous markers of hepatic function in patients receiving itraconazole treatment for prophylaxis of deep mycosis;Journal of Infection and Chemotherapy;2023-03

2. Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim;Clinical Immunology;2021-07